FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax
Strain selection timing and mRNA skepticism could limit the impact of Moderna’s game-changing mRNA flu shot.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.